BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29285580)

  • 1. Bone marrow findings in blast phase of polycythemia vera.
    Hidalgo López JE; Carballo-Zarate A; Verstovsek S; Wang SA; Hu S; Li S; Xu J; Zuo W; Tang Z; Yin CC; Medeiros LJ; Bueso-Ramos CE; Tang G
    Ann Hematol; 2018 Mar; 97(3):425-434. PubMed ID: 29285580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase.
    Hidalgo-Lopez JE; Kanagal-Shamanna R; Reyes S; Zhao C; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2019 Jun; 40():45-48. PubMed ID: 30928887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.
    Tang G; Hidalgo Lopez JE; Wang SA; Hu S; Ma J; Pierce S; Zuo W; Carballo-Zarate AA; Yin CC; Tang Z; Li S; Medeiros LJ; Verstovsek S; Bueso-Ramos CE
    Haematologica; 2017 Sep; 102(9):1511-1518. PubMed ID: 28473622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia.
    Gaidano G; Pastore C; Santini V; Nomdedeu J; Gamberi B; Capello D; Vischia F; Resegotti L; Mazza U; Ferrini PR; Lo Coco F; Saglio G
    Genes Chromosomes Cancer; 1997 Aug; 19(4):250-5. PubMed ID: 9258660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?
    Thiele J; Kvasnicka HM
    Curr Hematol Malig Rep; 2006 Jun; 1(2):87-92. PubMed ID: 20425337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage.
    Boiocchi L; Mathew S; Gianelli U; Iurlo A; Radice T; Barouk-Fox S; Knowles DM; Orazi A
    Mod Pathol; 2013 Dec; 26(12):1577-85. PubMed ID: 23787440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
    Iurlo A; Cattaneo D; Gianelli U
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT).
    Mesa RA; Verstovsek S; Cervantes F; Barosi G; Reilly JT; Dupriez B; Levine R; Le Bousse-Kerdiles MC; Wadleigh M; Campbell PJ; Silver RT; Vannucchi AM; Deeg HJ; Gisslinger H; Thomas D; Odenike O; Solberg LA; Gotlib J; Hexner E; Nimer SD; Kantarjian H; Orazi A; Vardiman JW; Thiele J; Tefferi A;
    Leuk Res; 2007 Jun; 31(6):737-40. PubMed ID: 17210175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.
    Cerquozzi S; Tefferi A
    Blood Cancer J; 2015 Nov; 5(11):e366. PubMed ID: 26565403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
    Passamonti F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S25-7. PubMed ID: 22035744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
    Gangat N; Guglielmelli P; Szuber N; Begna KH; Patnaik MM; Litzow MR; Al-Kali A; Foran JM; Palmer JM; Alkhateeb H; Elliott MA; Hanson CA; Pardanani A; Mannelli F; Vannucchi AM; Tefferi A
    Am J Hematol; 2021 Jul; 96(7):781-789. PubMed ID: 33844862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Megakaryoblastic transformation associated with disseminated intravascular coagulation in the course of polycythemia vera: a case report].
    Hino K; Sato S; Sakashita A; Tomoyasu S; Tsuruoka N; Koike T
    Rinsho Ketsueki; 1992 Apr; 33(4):500-6. PubMed ID: 1602615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotype and molecular cytogenetic studies in polycythemia vera.
    Andrieux JL; Demory JL
    Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
    Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
    Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cytogenetic abnormalities in patients with polycythemia vera.
    Sever M; Quintás-Cardama A; Pierce S; Zhou L; Kantarjian H; Verstovsek S
    Leuk Lymphoma; 2013 Dec; 54(12):2667-70. PubMed ID: 23488603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.
    Barraco D; Cerquozzi S; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Tefferi A
    Blood Cancer J; 2017 Mar; 7(3):e538. PubMed ID: 28282034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.